E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/22/2008 in the Prospect News Special Situations Daily.

Jade Capital reports 12.1% ownership of AMDL

By Lisa Kerner

Charlotte, N.C., Jan. 22 - AMDL, Inc. investor Minghui Jia, affiliated with Jade Capital Group Ltd., was appointed as a director of AMDL as a condition to the closing of the sale of Jade Pharmaceutical, Inc. to AMDL on Sept. 28, 2006.

Jia was re-elected as a director on Sept. 7 and currently is a director of AMDL, according to a schedule 13D filing with the Securities and Exchange Commission.

The investors, including Jade Capital, Jia and Fang Zheng, beneficially own 1,878,750 shares, or 12.1%, of the Tustin, Calif., biopharmaceutical company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.